Salinosporamides and Methods of Use Thereof
    6.
    发明申请
    Salinosporamides and Methods of Use Thereof 有权
    Salinosporamides及其使用方法

    公开(公告)号:US20140178354A1

    公开(公告)日:2014-06-26

    申请号:US14139692

    申请日:2013-12-23

    摘要: The present invention is based on the discovery that certain fermentation products of the marine actinomycete strains CNB392 and CNB476 are effective inhibitors of hyperproliferative mammalian cells. The CNB392 and CNB476 strains lie within the family Micromonosporaceae, and the generic epithet Salinospora has been proposed for this obligate marine group. The reaction products produced by this strain are classified as salinosporamides, and are particularly advantageous in treating neoplastic disorders due to their low molecular weight, low IC50 values, high pharmaceutical potency, and selectivity for cancer cells over fungi.

    摘要翻译: 本发明基于以下发现:海洋放线菌株CNB392和CNB476的某些发酵产物是过度增殖哺乳动物细胞的有效抑制剂。 CNB392和CNB476菌株位于Micromonosporaceae中,并且为该专业海洋群体提出了通用表型Salinospora。 由该菌株产生的反应产物分类为salinosporamide,并且由于其低分子量,低​​IC 50值,高药物效力和对真菌的癌细胞的选择性而特别有利于治疗肿瘤性疾病。

    Salinosporamides and methods for use thereof
    10.
    发明授权
    Salinosporamides and methods for use thereof 有权
    Salinosporamide及其使用方法

    公开(公告)号:US07176233B2

    公开(公告)日:2007-02-13

    申请号:US11147622

    申请日:2005-06-07

    摘要: The present invention is based on the discovery that certain fermentation products of the marine actinomycete strains CNB392 and CNB476 are effective inhibitors of hyperproliferative mammalian cells. The CNB392 and CNB476 strains lie within the family Micromonosporaceae, and the generic epithet Salinospora has been proposed for this obligate marine group. The reaction products produced by this strain are classified as salinosporamides, and are particularly advantageous in treating neoplastic disorders due to their low molecular weight, low IC50 values, high pharmaceutical potency, and selectivity for cancer cells over fungi.

    摘要翻译: 本发明基于以下发现:海洋放线菌株CNB392和CNB476的某些发酵产物是过度增殖哺乳动物细胞的有效抑制剂。 CNB392和CNB476菌株位于Micromonosporaceae中,并且为该专业海洋群体提出了通用表型Salinospora。 由该菌株产生的反应产物被归类为salinosporamide,并且由于其低分子量,低​​IC 50值,高药物效力和对真菌的癌细胞的选择性而特别有利于治疗肿瘤性疾病 。